XNCR · Xencor Inc · Executive Compensation

$24.41 +0.15 (+0.62%) At close · Sep 11

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$1.81B

74.35M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	President, Chief Executive Officer and Director	$742,800	—	$1,552,892	$2,727,018	$490,248	$8,247	$5,521,205
John Desjarlais	Chief Scientific Officer	$547,900	—	$422,392	$701,368	$301,345	$9,247	$1,982,252
Bart Jan Cornelissen	Chief Financial Officer	$491,600	—	$310,578	$515,712	$243,342	$81,164	$1,642,396
Celia E. Eckert	—	$491,600	—	$310,578	$515,712	$243,342	$9,247	$1,570,479
Nancy Valente	Former Chief Development Officer	$249,421	—	—	—	—	$181,345	$430,766

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	President, Chief Executive Officer and Director	$721,200	—	$1,246,193	$4,403,489	$432,700	$8,247	$6,811,829
John Kuch	Former Chief Financial Officer	$143,591	—	$322,458	$3,181,300	—	$640,179	$4,287,528
Bart Jan Cornelissen	Chief Financial Officer	$338,182	—	$910,811	$2,263,916	$156,938	$61,164	$3,731,011
Nancy Valente	Chief Development Officer	$556,200	—	$448,637	$1,462,211	$278,100	$122,625	$2,867,773
John Desjarlais	Chief Scientific Officer	$534,500	—	$473,543	$1,543,452	$267,250	$9,247	$2,827,992
Celia E. Eckert	—	$475,000	—	$299,084	$974,808	$213,750	$9,247	$1,971,889
General Counsel	—	$475,000	—	$299,084	$974,808	$213,750	$9,247	$1,971,889

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	President, Chief Executive Officer and Director	$700,200	—	$1,650,735	$5,249,673	$357,100	$8,247	$7,965,955
Nancy Valente	Chief Development Officer	$360,000	—	$1,063,743	$3,487,442	$153,000	$104,677	$5,168,862
John Desjarlais	Chief Scientific Officer	$518,900	—	$589,564	$1,874,883	$220,500	$9,247	$3,213,094
Allen S. Yang	M.D., Ph.D. Former Chief Medical Officer	$260,000	—	$471,639	$1,499,907	—	$712,818	$2,944,364
John Kuch	Former Chief Financial Officer	$468,000	—	$377,317	$1,199,929	$179,000	$9,247	$2,233,493
Celia E. Eckert	—	$457,600	—	$330,141	$1,049,931	$175,000	$9,247	$2,021,919
General Counsel	—	$457,600	—	$330,141	$1,049,931	$175,000	$9,247	$2,021,919

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	President, Chief Executive Officer and Director	$670,000	—	$1,493,825	$5,132,880	$402,000	$7,247	$7,705,952
John Desjarlais	Chief Scientific Officer	$485,000	—	$1,075,557	$1,168,043	$218,200	$8,247	$2,955,047
Allen S. Yang	M.D., Ph.D. Former Chief Medical Officer	$500,000	—	$995,883	$1,081,519	$225,000	$8,247	$2,810,649
John Kuch	Former Chief Financial Officer	$450,000	—	$697,124	$757,070	$202,500	$8,247	$2,114,941
General Counsel	—	$440,000	—	$597,518	$648,915	$198,000	$8,247	$1,892,680
Celia E. Eckert	—	$440,000	—	$597,518	$648,915	$198,000	$8,247	$1,892,680

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	President, Chief Executive Officer and Director	$625,000	—	$945,957	$3,340,406	$450,000	$8,932	$5,370,295
John Desjarlais	Chief Scientific Officer	$465,000	—	$448,103	$1,452,190	$251,100	$8,932	$2,625,325
Allen S. Yang	M.D., Ph.D. Former Chief Medical Officer	$480,000	—	$398,309	$1,290,835	$259,200	$8,932	$2,437,276
John Kuch	Chief Financial Officer	$415,000	—	$258,903	$839,034	$224,100	$8,932	$1,745,969
General Counsel	—	$400,000	—	$258,903	$839,034	$192,000	$8,932	$1,698,869

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Bassil I. Dahiyat	President, Chief Executive Officer and Director	$600,000	—	$761,969	$2,747,024	$363,000	$8,932	$4,480,925
John Desjarlais	Chief Scientific Officer	$437,000	—	$293,264	$939,711	$192,000	$8,932	$1,870,907
John Kuch	Chief Financial Officer	$400,000	—	$218,762	$700,447	$176,000	$8,932	$1,504,141
General Counsel	—	$386,000	—	$101,585	$325,289	$170,000	$16,854	$999,728
Allen S. Yang	Chief Medical Officer	$465,000	—	—	—	$205,000	$8,932	$678,932

Executive changes

Person	Role	Change	Effective	Filed
Raymond J. Deshaies	member of the Board of Directors	Appointed	2025-07-31	2025-07-31
Todd Simpson	Board of Directors	Appointed	—	2025-05-07
Nancy Valente	Executive Vice President and Chief Development Officer	Resigned	2025-06-06	2025-05-07
Todd Simpson	member of the Board of Directors	Appointed	2025-03-13	2025-03-13

Key facts CIK 1326732 CUSIP 98401F105 13F (30d) 65 filings 65 filers Visit website Investor relations